Literature DB >> 5809678

Hepatitis after exposure to halothane.

F M Klion, F Schaffner, H Popper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5809678     DOI: 10.7326/0003-4819-71-3-467

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  28 in total

1.  Lymphocyte transformation in halothane-related hepatitis.

Authors:  P J Moult; A B Adjukiewicz; P M Gaylarde; I Sarkany; S Sherlock
Journal:  Br Med J       Date:  1975-04-12

Review 2.  Halothane and liver damage.

Authors:  D Rosenak; A Halevy; R Orda
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

3.  The pathology of halothane hepatotoxicity in a guinea-pig model: a comparison with human halothane hepatitis.

Authors:  C A Lunam; P M Hall; M J Cousins
Journal:  Br J Exp Pathol       Date:  1989-10

4.  Elevation of serum xanthine oxidase following halothane anesthesia in the rat.

Authors:  S Giler; E Ventura; E Levy; I Urca; O Sperling; A de Vries
Journal:  Experientia       Date:  1976-05-15

5.  The current status of halothane.

Authors:  N Trieger; S Rubenstein; N Y Bronx
Journal:  Anesth Prog       Date:  1973-09

Review 6.  Halothane hepatitis--fact or fallacy?

Authors:  B R Simpson; L Strunin; B Walton
Journal:  Proc R Soc Med       Date:  1973-01

7.  Studies on drug-induced lupus erythematosus in mice. II. Drug-induced smooth muscle and skeletal muscle antibodies.

Authors:  J H ten Veen
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

8.  Halothane hepatitis--a preventable disease?

Authors:  P Sharpstone; D R Medley; R Williams
Journal:  Br Med J       Date:  1971-02-20

9.  Halothane hepatitis.

Authors:  A H Qizilbash
Journal:  Can Med Assoc J       Date:  1973-01-20       Impact factor: 8.262

10.  Jaundice after multiple halothane anaesthetics administered during the treatment of carcinoma of the uterus.

Authors:  P Davis; C D Holdsworth
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.